{"id":83523,"date":"2020-04-16T23:10:44","date_gmt":"2020-04-17T02:10:44","guid":{"rendered":"https:\/\/megalabs.global\/por\/?p=83523"},"modified":"2020-04-16T23:10:44","modified_gmt":"2020-04-17T02:10:44","slug":"ivermectina-un-nuevo-soldado-contra-la-lucha-de-covid-19","status":"publish","type":"post","link":"https:\/\/megalabs.global\/por\/ivermectina-un-nuevo-soldado-contra-la-lucha-de-covid-19\/","title":{"rendered":"IVERMECTINA: Un nuevo soldado contra la lucha de COVID-19."},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;100&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; row_height_use_pixel=&#8221;&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; medium_width=&#8221;0&#8243; zoom_width=&#8221;0&#8243; zoom_height=&#8221;0&#8243; column_width_pixel=&#8221;800&#8243;][vc_column_text]Un estudio in vitro conducido por el Instituto Monash de Descubrimientos en Biomedicina (BID) y el Hospital Real de Melbourne de Australia, ha mostrado que Ivermectina es capaz de detener la replicaci\u00f3n viral de SARS-CoV-2 en menos de 48 hs.<br \/>\nPreviamente, mediante estudios in vitro, Ivermectina mostr\u00f3 ser efectivo contra diversos virus como VIH, Zika, Dengue e Influenza. Teniendo presente dichos hallazgos, Caly y colaboradores han decidido estudiar el comportamiento de este medicamento en c\u00e9lulas Vero-hSLAM infectadas previamente con SARS-CoV-2. Mediante PCR, luego de 24 horas de incubaci\u00f3n con el medicamento se observ\u00f3 una reducci\u00f3n del 93% en la carga viral de ARN. A las 48hs de incubaci\u00f3n con el medicamento se observ\u00f3 la p\u00e9rdida efectiva de la carga viral esencial (disminuyendo m\u00e1s de 5.000 veces respecto a condiciones iniciales, 99.8%) en las c\u00e9lulas infectadas y en su sobrenadante. De esta forma Ivermectina mostr\u00f3 in vitro su acci\u00f3n antiviral para SARS-CoV-2 en una sola dosis, en un per\u00edodo de 24-48 hs.<\/p>\n<p><em>\u00bfQui\u00e9n es Ivermectina y c\u00f3mo inhibe SARS-CoV-2?<\/em><br \/>\nSe trata de un antiparasitario descubierto en la d\u00e9cada de los a\u00f1os 70, que result\u00f3 revolucionario por su amplio espectro, al actuar contra nem\u00e1todos y artr\u00f3podos. Si bien inicialmente fue utilizado en animales, desde 1988 ha sido usado exitosamente en humanos, mejorando la nutrici\u00f3n y calidad de vida de billones de personas. Ha mostrado ser seguro, eficaz y bien tolerado para diversas infecciones parasitarias (en especial Oncocercosis).<br \/>\nIvermectina es un inhibidor de la interacci\u00f3n entre las prote\u00ednas de la envoltura viral y la c\u00e9lula hu\u00e9sped. Los autores plantean que, de la misma forma que ocurre con VIH, Zika, Dengue e Influenza; Ivermetcin inhibe la importaci\u00f3n viral al n\u00facleo. Esto lo logra ya que interacciona con la prote\u00edna citos\u00f3lica de importaci\u00f3n nuclear IMP\u03b1\/\u03b21, e impide su unic\u00f3n con las prote\u00ednas de la c\u00e1pside viral.<br \/>\nEl uso de Ivermectina para combatir COVID-19 depender\u00e1 de los resultados de m\u00e1s pruebas pre-cl\u00ednicas y cl\u00ednicas, que confirmen los resultados recientemente obtenidos. Este medicamento ya est\u00e1 disponible en todo el mundo; con lo cual, de ser aprobada para su tratamiento en COVID-19, su aplicaci\u00f3n para COVID-19 podr\u00eda ser inmediata.<\/p>\n<p><strong>Bibliograf\u00eda:<\/strong><br \/>\n&#8211; Caly L, et al. The FDA-approved Drug Ivermectina inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research. 2020. 104787. Doi: 10.1016<br \/>\n&#8211; Crump A, et al. Ivermectina, \u201cWonder drug\u201d from Japan: the human use perspective\u201d. Proc Jpn Acad Ser B Phys Biol Sci. 2011. 87(2): 13\u201328. Doi: 10.2183\/pjab.87.13[\/vc_column_text][\/vc_column][\/vc_row][vc_row unlock_row=&#8221;&#8221; row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;100&#8243; gutter_size=&#8221;3&#8243; column_width_use_pixel=&#8221;yes&#8221; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; row_height_use_pixel=&#8221;&#8221; column_width_pixel=&#8221;800&#8243;][vc_column width=&#8221;1\/1&#8243;][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; border_color=&#8221;color-877404&#8243; border_style=&#8221;solid&#8221; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1572995729128{border-top-width: 1px !important;border-bottom-width: 1px !important;padding-top: 18px !important;padding-bottom: 18px !important;}&#8221; el_class=&#8221;descarga-pdf&#8221; limit_content=&#8221;&#8221;][vc_column_inner width=&#8221;1\/1&#8243;][vc_icon position=&#8221;left&#8221; icon_image=&#8221;82110&#8243; icon_color=&#8221;color-877404&#8243; media_size=&#8221;42&#8243; text_font=&#8221;font-195522&#8243; text_weight=&#8221;700&#8243; linked_title=&#8221;yes&#8221; title=&#8221;Descargar Documento&#8221; link=&#8221;url:%2Fwp-content%2Fuploads%2F2020%2F04%2FConexion-Megalabs-Ivermectina.pdf|title:Conexion%20Megalabs%20-%20Ivermectina|target:%20_blank|&#8221;]Conexion Megalabs &#8211; Ivermectina[\/vc_icon][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/1&#8243;][vc_single_image media=&#8221;83524&#8243; media_width_use_pixel=&#8221;yes&#8221; alignment=&#8221;center&#8221; media_width_pixel=&#8221;700&#8243;][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;100&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; row_height_use_pixel=&#8221;&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; medium_width=&#8221;0&#8243; zoom_width=&#8221;0&#8243; zoom_height=&#8221;0&#8243; column_width_pixel=&#8221;800&#8243;][vc_column_text]Un estudio [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":83528,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[107],"tags":[],"class_list":["post-83523","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-estudios-preclinicos"],"_links":{"self":[{"href":"https:\/\/megalabs.global\/por\/wp-json\/wp\/v2\/posts\/83523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/megalabs.global\/por\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/megalabs.global\/por\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/megalabs.global\/por\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/megalabs.global\/por\/wp-json\/wp\/v2\/comments?post=83523"}],"version-history":[{"count":0,"href":"https:\/\/megalabs.global\/por\/wp-json\/wp\/v2\/posts\/83523\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/megalabs.global\/por\/wp-json\/wp\/v2\/media\/83528"}],"wp:attachment":[{"href":"https:\/\/megalabs.global\/por\/wp-json\/wp\/v2\/media?parent=83523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/megalabs.global\/por\/wp-json\/wp\/v2\/categories?post=83523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/megalabs.global\/por\/wp-json\/wp\/v2\/tags?post=83523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}